The science was there. Women paid the price.

April 14, 2026
The science was there. Women paid the price. RegenCen article

What the FDA’s reversal means for women – and for long-term health

For more than two decades, hormone replacement therapy (HRT) carried a warning that shaped medical decision-making, public perception, and women’s lives. Many were advised to avoid it. Others were never offered it at all.

In late 2025, that position changed. In a widely discussed editorial, Marty Makary, MD, MPH, announced that the FDA is removing the black box warning from hormone replacement therapy products – acknowledging that the long-standing fear linking HRT to increased breast cancer mortality was not supported by clinical evidence.

 

“Over the past two decades, tens of millions of women have been denied, not offered, or avoided hormone replacement therapy because of a medical dogma that it would increase their risk of dying of breast cancer. Clinical trials, however, don’t support that association.”

– Marty Makary, MD, MPH, FDA Commissioner | The Wall Street Journal, Nov 2025

 

This announcement marks a meaningful shift – not because the science is new, but because it has finally been formally acknowledged.

What the evidence now clearly supports

When hormone therapy is appropriately prescribed and initiated within the right window, the benefits extend well beyond symptom relief.

Current evidence shows that hormone replacement therapy, when started within ten years of menopause, is associated with:

  • A significantly lower risk of fatal coronary events
  • A substantial reduction in osteoporotic fractures
  • Lower rates of cognitive decline and Alzheimer’s disease
  • No increase in breast cancer mortality

For years, many clinicians practicing in menopause and longevity medicine have been explaining this to patients. The FDA’s update simply aligns public policy with what data – and patient outcomes – have shown all along.

Why timing and expertise matter

Not all hormone therapy is the same. Outcomes depend on when therapy is started, how it is prescribed, and who is overseeing care.

While this change may influence attitudes, it does not automatically translate into widespread expertise. Many physicians received little formal training in menopause management and remain cautious – or unfamiliar – with modern, individualized hormone restoration.

How to get started

Hormone therapy begins with a conversation – not a prescription.

At RegenCen, care is overseen by certified menopause practitioners and guided by hormone testing, appropriate screening, and ongoing monitoring to ensure treatment is safe and effective over time.

The goal isn’t to feel different. It’s to feel like yourself again – the way you did in your 30s and 40s, without the monthly cycle. When hormones are properly balanced, most women simply feel normal: steadier energy, better sleep, improved mood, and greater resilience.

Questions women ask most:

Can I use hormone therapy if I have a family history of breast cancer?

Yes. A family history of breast cancer does not preclude hormone therapy. Current evidence shows that HRT does not increase breast cancer mortality in these patients. At RegenCen, women with a family history undergo individualized planning and are required to maintain appropriate annual breast imaging, including mammography or MRI when indicated.

What if I have a personal history of breast cancer?

In many cases, hormone therapy is still possible – but it must be carefully customized. For women with a personal history of breast cancer, treatment often focuses on vaginal estrogen and testosterone, paired with a prescription medication that prevents testosterone from converting to estrogen. This approach can be life-changing.

The most commonly reported benefits include:

  • Significant improvement in vaginal dryness and urinary symptoms
  • Enhanced comfort and intimacy (often combined with in-office vaginal rejuvenation to restore estrogen-deficient tissue)
  • Improved mood, sleep, strength, stamina, and metabolic health
  • In these cases, screening, coordination, and clinical oversight are especially important – and essential

When should I start HRT?

Hormone therapy can be considered when symptoms of hormone deficiency begin – and is especially important after menstrual cycles stop. It’s also never too late: many women years or even decades past menopause still experience significant improvements in vaginal comfort, sleep, energy, and overall quality of life with individualized care.

This is a moment worth acting on.

RegenCen is proud to have Menopause Society Certified Practitioners in every region we serve.

📍 You can find RegenCen in:

Schedule your consultation at RegenCen near you in Michigan or Florida today.

Posted in General